{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:36:11Z","timestamp":1793705771237,"version":"4.5.1"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Diabetes mellitus (DM) and tuberculosis (TB) are significant global health challenges that complicate diagnosis, treatment, and management due to their interrelated nature. DM increases TB risk and worsens outcomes, highlighting the need for early detection and effective management. This review summarizes recent advancements in biomarkers for DM-TB comorbidity, including microbial, metabolic, immunological, inflammatory, clinical, and genetic markers. We identified 30 relevant studies, through a literature search using keywords related to DM, TB, and biomarkers. Key findings include specific gut microbiota genera and lipid mediators that show promise for early diagnosis and treatment. Immunological biomarkers like altered CD8+ T cells and NK cells provide insights into disease severity and treatment monitoring. Inflammatory markers such as elevated CRP, ferritin, and IL-6 reflect heightened inflammation and could guide treatment strategies. Clinical biomarkers, including serum CA-125 (sensitivity 88.14%, specificity 95.83%) and AUC\/MIC ratios of anti-TB drugs (e.g., moxifloxacin \u226567; sensitivity 97.3%, specificity 90.0%), demonstrate high diagnostic accuracy. Future research should focus on validating these biomarkers across diverse populations and integrating them into clinical practice to enhance DM-TB management and contribute to global disease control efforts.<\/jats:p>","DOI":"10.3389\/fendo.2025.1630603","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T04:10:19Z","timestamp":1755144619000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Recent advances in biomarkers for diabetes mellitus and tuberculosis comorbidity: a comprehensive review"],"prefix":"10.3389","volume":"16","author":[{"given":"Lihua","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2147\/RMHP.S436873","article-title":"Prevalence and associated factors of diabetes mellitus among newly enrolled tuberculosis patients in lubumbashi (DRC)","volume":"17","author":"Kakisingi","year":"2024","journal-title":"Risk Manage Healthcare Policy"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2018.02.023","article-title":"IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045","volume":"138","author":"Cho","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/tropicalmed6010008","article-title":"The interaction of diabetes and tuberculosis: translating research to policy and practice","volume":"6","author":"van Crevel","year":"2021","journal-title":"Trop Med Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e35670","DOI":"10.1016\/j.heliyon.2024.e35670","article-title":"Tuberculosis patients with diabetes co-morbidity experience reduced Mycobacterium tuberculosis complex clearance","volume":"10","author":"Danso","year":"2024","journal-title":"Heliyon"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.14.0811","article-title":"Diabetes mellitus is associated with cavities, smear grade, and multidrug-resistant tuberculosis in Georgia","volume":"19","author":"Magee","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad118","article-title":"Yield and efficiency of a population-based mass tuberculosis screening intervention among persons with diabetes in Jiangsu province, China","volume":"77","author":"Liu","year":"2023","journal-title":"Clin Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1186\/s12879-024-09931-8","article-title":"Latent tuberculosis infection and diagnostic performance of the tuberculin skin test among type 2 diabetics in Sana\u2019a city, Yemen","volume":"24","author":"Abdul-Ghani","year":"2024","journal-title":"BMC Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01067-15","article-title":"Clinical pharmacokinetics of rifampin in patients with tuberculosis and type 2 diabetes mellitus: association with biochemical and immunological parameters","volume":"59","author":"Medell\u00edn-Garibay","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"B9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.tube.2017.01.006","article-title":"The effect size of type 2 diabetes mellitus on tuberculosis drug resistance and adverse treatment outcomes","volume":"103","author":"Perez-Navarro","year":"2017","journal-title":"Tuberc (Edinburgh Scotland)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2313683","DOI":"10.1080\/07853890.2024.2313683","article-title":"Tuberculosis (TB) treatment challenges in TB-diabetes comorbid patients: a systematic review and meta-analysis","volume":"56","author":"Khattak","year":"2024","journal-title":"Ann Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1177\/193229681100500127","article-title":"Diabetes and biomarkers","volume":"5","author":"Caveney","year":"2011","journal-title":"J Diabetes Sci Technol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12902-020-00653-x","article-title":"Metabolite biomarkers of type 2 diabetes mellitus and pre-diabetes: a systematic review and meta-analysis","volume":"20","author":"Long","year":"2020","journal-title":"BMC Endocrine Disord"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-019-0380-2","article-title":"A systematic review of biomarkers to detect active tuberculosis","volume":"4","author":"MacLean","year":"2019","journal-title":"Nat Microbiol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab755","article-title":"Tuberculosis preventive therapy for people with diabetes mellitus","volume":"74","author":"Olomi","year":"2022","journal-title":"Clin Infect Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12931-023-02312-w","article-title":"Gut microbiota composition can reflect immune responses of latent tuberculosis infection in patients with poorly controlled diabetes","volume":"24","author":"Huang","year":"2023","journal-title":"Respir Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e0177224","DOI":"10.1128\/spectrum.01772-24","article-title":"Disorders of gut microbiota and fecal-serum metabolic patterns are associated with pulmonary tuberculosis and pulmonary tuberculosis comorbid type 2 diabetes mellitus","author":"Wang","year":"2025","journal-title":"Microbiol Spectrum"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2217\/bmm-2018-0050","article-title":"Metabolomics applied to the discovery of tuberculosis and diabetes mellitus biomarkers","volume":"12","author":"Salgado-Bustamante","year":"2018","journal-title":"Biomarkers Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00335","article-title":"Plasma eicosanoid levels in tuberculosis and tuberculosis-diabetes co-morbidity are associated with lung pathology and bacterial burden","volume":"9","author":"Pavan Kumar","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ebiom.2018.05.011","article-title":"Patients with concurrent tuberculosis and diabetes have a pro-atherogenic plasma lipid profile","volume":"32","author":"Vrieling","year":"2018","journal-title":"EBioMedicine"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e0057723","DOI":"10.1128\/spectrum.00577-23","article-title":"Integration of metabolomics and transcriptomics reveals major metabolic pathways and potential biomarkers involved in pulmonary tuberculosis and pulmonary tuberculosis-complicated diabetes","volume":"11","author":"Wang","year":"2023","journal-title":"Microbiol Spectrum"},{"key":"B21","doi-asserted-by":"publisher","first-page":"18669","DOI":"10.1038\/s41598-019-54983-5","article-title":"Plasma metabolomics in tuberculosis patients with and without concurrent type 2 diabetes at diagnosis and during antibiotic treatment","volume":"9","author":"Vrieling","year":"2019","journal-title":"Sci Rep"},{"key":"B22","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.1038\/s41598-022-08201-4","article-title":"Targeted metabolomics analysis of serum and Mycobacterium tuberculosis antigen-stimulated blood cultures of pediatric patients with active and latent tuberculosis","volume":"12","author":"Magdalena","year":"2022","journal-title":"Sci Rep"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1447161","article-title":"Cytokine and chemokine profiles in pulmonary tuberculosis with pre-diabetes","volume":"15","author":"Rajamanickam","year":"2024","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12421","article-title":"Type 2 diabetes mellitus is associated with altered CD8(+) T and natural killer cell function in pulmonary tuberculosis","volume":"144","author":"Kumar","year":"2015","journal-title":"Immunology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv484","article-title":"Impaired Cytokine but Enhanced Cytotoxic Marker Expression in Mycobacterium tuberculosis-Induced CD8+ T Cells in Individuals With Type 2 Diabetes and Latent Mycobacterium tuberculosis Infection","volume":"213","author":"Kumar","year":"2016","journal-title":"J Infect Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.716819","article-title":"Type 2 diabetes mellitus and latent tuberculosis infection moderately influence innate lymphoid cell immune responses in Uganda","volume":"12","author":"Ssekamatte","year":"2021","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.756854","article-title":"Decreased frequencies of gamma\/delta T cells expressing th1\/th17 cytokine, cytotoxic, and immune markers in latent tuberculosis-diabetes\/pre-diabetes comorbidity","volume":"11","author":"Kathamuthu","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1177\/147323001103900113","article-title":"Significant increase in natural-killer T cells in patients with tuberculosis complicated by type 2 diabetes mellitus","volume":"39","author":"Zhang","year":"2011","journal-title":"J Int Med Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/S1472-9792(13)70015-5","article-title":"Differential expression of monocyte surface markers among TB patients with diabetes co-morbidity","author":"Stew","year":"2013","journal-title":"Tuberc (Edinburgh Scotland)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13040919","article-title":"Development and validation of early alert model for diabetes mellitus-tuberculosis comorbidity","volume":"13","author":"Ye","year":"2025","journal-title":"Microorganisms"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.5588\/pha.16.0114","article-title":"Diabetes and pre-diabetes in tuberculosis patients in western Kenya using point-of-care glycated haemoglobin","volume":"7","author":"Owiti","year":"2017","journal-title":"Public Health Action"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2017.11.011","article-title":"Modulation of iron status biomarkers in tuberculosis-diabetes co-morbidity","volume":"108","author":"Kumar","year":"2018","journal-title":"Tuberc (Edinburgh Scotland)"},{"key":"B33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/cid\/ciaa751","article-title":"Impact of intermediate hyperglycemia and diabetes on immune dysfunction in tuberculosis","volume":"72","author":"Eckold","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B34","article-title":"Study of correlation of CD4, CD8 count with tuberculous pneumonia and non tuberculous bacterial pneumonia in type 2 diabetes mellitu","volume":"70","author":"Kumar","year":"2022","journal-title":"J Assoc Phys India"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2018.07.001","article-title":"Serum levels of chemokines IP-10, IL-8 and SDF-1 serve as good biomarkers for diabetes-tuberculosis nexus","volume":"32","author":"Aravindhan","year":"2018","journal-title":"J Diabetes its Complicat"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.640707","article-title":"Mycobacterial growth inhibition assay (MGIA) as a host directed diagnostic tool for the evaluation of the immune response in subjects living with type 2 diabetes mellitus","volume":"11","author":"Bobadilla-Del-Valle","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S377465","article-title":"The novel predictive biomarkers for type 2 diabetes mellitus in active pulmonary tuberculosis patients","volume":"15","author":"Yu","year":"2022","journal-title":"Infect Drug Resist"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S512075","article-title":"Development and validation of a predictive model using inflammatory biomarkers for active tuberculosis risk in diabetic patients","volume":"18","author":"Zhang","year":"2025","journal-title":"J Inflammation Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae329","article-title":"Drug exposure and treatment outcomes in patients with multidrug-resistant tuberculosis and diabetes mellitus: A multicenter prospective cohort study from China","volume":"79","author":"Zhu","year":"2024","journal-title":"Clin Infect Dis"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2017.08.006","article-title":"Clinical significance of serum CA-125, CA19\u20139 and CEA in pulmonary tuberculosis with and without type 2 diabetes","volume":"107","author":"Du","year":"2017","journal-title":"Tuberc (Edinburgh Scotland)"},{"key":"B41","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1186\/s12879-021-06152-1","article-title":"Mean platelet volume (MPV): new diagnostic indices for co-morbidity of tuberculosis and diabetes mellitus","volume":"21","author":"Xu","year":"2021","journal-title":"BMC Infect Dis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.17.206227","article-title":"Accuracy of diabetes screening methods used for people with tuberculosis, Indonesia, Peru, Romania, South Africa","volume":"96","author":"Grint","year":"2018","journal-title":"Bull World Health Org"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S318071","article-title":"Identification of hub genes associated with diabetes mellitus and tuberculosis using bioinformatic analysis","volume":"14","author":"Liu","year":"2021","journal-title":"Int J Gen Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2015.150210","article-title":"Proteomic analysis of plasma in adult active pulmonary tuberculosis patients with diabetes mellitus","volume":"61","author":"Zhang","year":"2015","journal-title":"Clin Lab"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.18.0323","article-title":"Curbing the diabetes and tuberculosis co-epidemic: the potential role of China","volume":"23","author":"Bao","year":"2019","journal-title":"Int J Tuberc Lung Dis"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2017.06.014","article-title":"Tuberculosis and diabetes in Nigerian patients with and without HIV","volume":"61","author":"Lawson","year":"2017","journal-title":"Int J Infect Dis: IJID"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13935","article-title":"Diabetes mellitus comorbidity in patients enrolled in tuberculosis drug efficacy trials around the world: A systematic review","volume":"85","author":"Lutfiana","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1122255","article-title":"Immunologic, metabolic and genetic impact of diabetes on tuberculosis susceptibility","volume":"14","author":"Ssekamatte","year":"2023","journal-title":"Front Immunol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1630603\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T04:10:20Z","timestamp":1755144620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1630603\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":48,"alternative-id":["10.3389\/fendo.2025.1630603"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1630603","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]},"article-number":"1630603"}}